Cas no 103904-74-1 (2-(14-hydroxypentadeca-7,9-dien-5-yl)benzoic Acid)
2-(14-hydroxypentadeca-7,9-dien-5-yl)benzoic Acid Chemical and Physical Properties
Names and Identifiers
-
- 2-(14-hydroxypentadeca-7,9-dien-5-yl)benzoic Acid
- CTK0I4337
- ACMC-20m6p4
- 6-(8(Z),11(Z)-pentadecadienyl)salicylic acid
- anacardic acid (C15:2)
- 2-[(7Z,9E)-14-hydroxypentadeca-7,9-dien-5-yl]benzoic Acid
- C15:2-anacardic acid
- 6-[8(Z),11(Z)-pentadecadienyl]salicylic acid
- 6-[8(Z),11(Z)-pentadecadienyl] salicylic acid
- 2-hydroxy-6-pentadeca-8c,11c-dienyl-benzoic acid
- 6-[8'(Z),11'(Z)-pentadecadienyl]salicylic acid
- CTK0I4337; ACMC-20m6p4; 6-(8(Z),11(Z)-pentadecadienyl)salicylic acid; anacardic acid (C15:2); 2-[(7Z,9E)-14-hydroxypentadeca-7,9-dien-5-yl]benzoic Acid; C15:2-anacardic acid; 6-[8(Z),11(Z)-pentadecadienyl]salicylic acid; 6-[8(Z),11(Z)-pentadecadienyl] salicylic acid; 2-hydroxy-6-pentadeca-8c,11c-dienyl-benzoic acid; 6-[8'(Z),11'(Z)-pentadecadienyl]salicylic acid;
- 103904-74-1
- ana-cardic acid
- Anacardic acid diene
- 2-Hydroxy-6-(8Z,11Z)-8,11-pentadecadien-1-yl-Benzoic acid
- 2-Hydroxy-6-8Z,11Z-pentadecadien-1-yl-benzoic acid
- SCHEMBL154719
- 2-Hydroxy-6-(8,11-pentadecadienyl)-(Z,Z)-Benzoic acid
- CHEMBL451725
- 2-hydroxy-6-[(8Z,11Z)-pentadeca-8,11-dien-1-yl]benzoic acid
- DTXSID10872876
- AKOS040735494
- Benzoic acid, 2-hydroxy-6-(8Z,11Z)-8,11-pentadecadien-1-yl-
-
- Inchi: 1S/C22H32O3/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-16-19-17-15-18-20(23)21(19)22(24)25/h4-5,7-8,15,17-18,23H,2-3,6,9-14,16H2,1H3,(H,24,25)/b5-4-,8-7-
- InChI Key: KAOMOVYHGLSFHQ-UTOQUPLUSA-N
- SMILES: OC1=CC=CC(=C1C(=O)O)CCCCCCC/C=C\C/C=C\CCC
Computed Properties
- Exact Mass: 344.23526
- Monoisotopic Mass: 344.23514488g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 2
- Hydrogen Bond Acceptor Count: 3
- Heavy Atom Count: 25
- Rotatable Bond Count: 13
- Complexity: 400
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 2
- Undefined Bond Stereocenter Count: 0
- XLogP3: 7.9
- Topological Polar Surface Area: 57.5?2
Experimental Properties
- Solubility: DMF:20mg/mL; DMSO:15mg/mL;乙醇:22mg/mL;乙醇:PBS(pH 7.2) (1:1): 0.5 mg/ml
- PSA: 57.53
2-(14-hydroxypentadeca-7,9-dien-5-yl)benzoic Acid Security Information
- Storage Condition:Store at -20°C
2-(14-hydroxypentadeca-7,9-dien-5-yl)benzoic Acid Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| WU HAN AN JIE KAI Biomedical Technology Co., Ltd. | ajci66664-1mg |
Anacardic Acid Diene |
103904-74-1 | 98% | 1mg |
¥1764.00 | 2023-09-08 | |
| WU HAN AN JIE KAI Biomedical Technology Co., Ltd. | ajci66664-5mg |
Anacardic Acid Diene |
103904-74-1 | 98% | 5mg |
¥7351.00 | 2023-09-08 | |
| WU HAN AN JIE KAI Biomedical Technology Co., Ltd. | ajci66664-10mg |
Anacardic Acid Diene |
103904-74-1 | 98% | 10mg |
¥12972.00 | 2023-09-08 | |
| WU HAN AN JIE KAI Biomedical Technology Co., Ltd. | ajci66664-500ug |
Anacardic Acid Diene |
103904-74-1 | 98% | 500ug |
¥931.00 | 2023-09-08 | |
| 1PlusChem | 1P0085PK-1mg |
2-[(7Z,9E)-14-hydroxypentadeca-7,9-dien-5-yl]benzoic acid |
103904-74-1 | ≥95% | 1mg |
$203.00 | 2023-12-26 | |
| 1PlusChem | 1P0085PK-5mg |
2-[(7Z,9E)-14-hydroxypentadeca-7,9-dien-5-yl]benzoic acid |
103904-74-1 | ≥95% | 5mg |
$802.00 | 2023-12-26 | |
| 1PlusChem | 1P0085PK-10mg |
2-[(7Z,9E)-14-hydroxypentadeca-7,9-dien-5-yl]benzoic acid |
103904-74-1 | ≥95% | 10mg |
$1385.00 | 2023-12-26 | |
| A2B Chem LLC | AD79848-1mg |
2-[(7Z,9E)-14-hydroxypentadeca-7,9-dien-5-yl]benzoic acid |
103904-74-1 | ≥95% | 1mg |
$138.00 | 2024-04-20 | |
| A2B Chem LLC | AD79848-5mg |
2-[(7Z,9E)-14-hydroxypentadeca-7,9-dien-5-yl]benzoic acid |
103904-74-1 | ≥95% | 5mg |
$614.00 | 2024-04-20 | |
| A2B Chem LLC | AD79848-10mg |
2-[(7Z,9E)-14-hydroxypentadeca-7,9-dien-5-yl]benzoic acid |
103904-74-1 | ≥95% | 10mg |
$1081.00 | 2024-04-20 |
2-(14-hydroxypentadeca-7,9-dien-5-yl)benzoic Acid Related Literature
-
Kay S. McMillan,Anthony G. McCluskey,Annette Sorensen,Marie Boyd,Michele Zagnoni Analyst, 2016,141, 100-110
-
Qiyuan Wu,Shangmin Xiong,Peichuan Shen,Shen Zhao,Alexander Orlov Catal. Sci. Technol., 2015,5, 2059-2064
-
Eric Besson,Stéphane Gastaldi,Emily Bloch,Selma Aslan,Hakim Karoui,Olivier Ouari,Micael Hardy Analyst, 2019,144, 4194-4203
-
Sowmyalakshmi Venkataraman RSC Adv., 2015,5, 73807-73813
Additional information on 2-(14-hydroxypentadeca-7,9-dien-5-yl)benzoic Acid
2-(14-Hydroxypentadeca-7,9-dien-5-yl)benzoic Acid: A Comprehensive Overview
2-(14-Hydroxypentadeca-7,9-dien-5-yl)benzoic Acid, identified by the CAS registry number 103904-74-1, is a unique organic compound that has garnered attention in both academic and industrial research. This compound is characterized by its complex structure, which includes a benzoic acid moiety attached to a pentadeca chain featuring hydroxyl and double bond functionalities. The presence of these functional groups imparts distinctive chemical and biological properties to the molecule, making it a subject of interest in various fields such as pharmacology, material science, and analytical chemistry.
The structural complexity of 2-(14-hydroxypentadeca-7,9-dien-5-yl)benzoic acid lies in its pentadecanoid backbone. The pentadecanoid series is known for its diverse biological activities, and the substitution pattern in this compound further enhances its potential applications. The hydroxyl group at position 14 and the conjugated double bonds at positions 7 and 9 contribute to the molecule's stability and reactivity. Recent studies have explored the role of such structures in lipid signaling pathways, suggesting potential therapeutic applications in inflammation and neurodegenerative diseases.
From a synthetic perspective, the preparation of 2-(14-hydroxypentadeca-7,9-dien-5-yl)benzoic acid involves multi-step organic reactions, including oxidation, reduction, and coupling processes. Researchers have optimized these protocols to achieve higher yields and purities, which are critical for downstream applications. The use of advanced analytical techniques such as NMR spectroscopy and mass spectrometry has enabled precise characterization of the compound's structure, ensuring its reliability in research settings.
The biological activity of 2-(14-hydroxypentadeca-7,9-dien-5-yl)benzoic acid has been a focal point of recent investigations. Studies have demonstrated its ability to modulate cellular signaling pathways involved in immune response and apoptosis. For instance, experiments using human cancer cell lines have shown that this compound exhibits selective cytotoxicity, potentially making it a candidate for anticancer drug development. Additionally, its anti-inflammatory properties have been explored in preclinical models, highlighting its potential as a therapeutic agent for chronic inflammatory conditions.
In terms of industrial applications, the unique properties of 2-(14-hydroxypentadeca-7,9-dien-5-yl)benzoic acid make it a valuable component in specialty chemicals and materials science. Its ability to form stable complexes with metal ions has led to its use in catalysis and sensor technologies. Furthermore, the compound's compatibility with various polymer systems has opened avenues for its application in biodegradable materials and drug delivery systems.
The growing interest in natural product-derived compounds has also influenced research on 2-(14-hydroxypentadeca-7,9-dien-5-y)l)benzoic acid. Scientists are exploring methods to biosynthesize this compound using microbial fermentation or enzymatic catalysis, which could offer more sustainable production routes compared to traditional chemical synthesis. These advancements not only enhance the scalability of production but also align with current trends toward greener chemical processes.
In conclusion, 2-(14-hydroxypentadeca-7,9-dien--5-y)-l)benzoic acid, with its distinctive structure and versatile properties, continues to be a subject of intense research across multiple disciplines. As new insights into its synthesis, biological activity
103904-74-1 (2-(14-hydroxypentadeca-7,9-dien-5-yl)benzoic Acid) Related Products
- 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
- 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
- 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
- 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
- 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
- 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
- 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
- 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
- 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
- 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)